Article
Clonal hematopoiesis of indeterminate potential: a multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases.
Military Medical Research - 14 Oct 2025
Zhang Jing-Lei, Tong Shuo-Lan, Zhuang Qi-Qi, Jin Sheng-Jie, Li Jia-Qiu, Sun Jie
Abstract excerpt
Clonal hematopoiesis of indeterminate potential (CHIP), driven by leukemia-related somatic mutations in hematopoietic stem cells, previously recognized as a major risk factor for hematological malignancies, has now emerged as a potent risk factor for chronic inflammation and diverse non-hematologic diseases. CHIP-associated DNA methyltransferase 3 alpha (DNMT3A), tet methylcytosine dioxygenase 2 (TET2), and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
